AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters

Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters

Study flags need to monitor frailty risks with GLP-1 drugs for older adults Reuters

July 14, 2026 at 11:16 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

No locations linked to this story

Tags

frailty frailty risks glp-1 drugs health health monitoring health risks health study medication medication risks monitoring older adults study

All Coverage

Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUU1ZX1Zfd0F3c1A5M0ZuNktDa3MzY0xMZklnTEN3cjdqam5CWWpTM2tHamp3YXhFMjVPSm43SlFweUk2R3RuS1FJa1A0WUFtSTNVUlYxWjdRb2RXSmczOW1fUDBkcTNPVWZlR29ocThIWnFpUnhCX09LYVVqLTFQc1RjRHI3WFlwYjIzVVU2aEhOa1JBRlNoV2pnVWRoTFM3YXJYYXFJcUhoYXZTd1ZpSmRwX3NKT05kM3Vqc3FR?oc=5" target="_blank">Study flags need to monitor frailty risks with GLP-1 drugs for older adults</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug - Reuters

Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug Reuters

August 12, 2026 at 04:25 PM

EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters

EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters

August 17, 2026 at 03:45 PM

Novo begins study to find lowest effective dose for Wegovy pill - Reuters

Novo begins study to find lowest effective dose for Wegovy pill Reuters

August 19, 2026 at 03:26 PM

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com

August 12, 2026 at 10:27 AM

As Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters

As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters

August 12, 2026 at 06:34 PM

Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters

Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters

August 13, 2026 at 06:00 PM